Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

amLODIPine-olmesartan

amLODIPine-olmesartan
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Azor TABLET, ORAL 5 mg-20 mg, 5 mg-40 mg    
Azor TABLET, ORAL 10 mg-20 mg, 10 mg-40 mg    
VIEW MORE Dihydropyridines, Angiotensin II Receptor Antagonists
CLASS
242808, 243208
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

amLODIPine-olmesartan (Azor)                                            

  • 5 mg-20 mg tablet oral Daily                                            
  • 10 mg-20 mg tablet oral Daily

amLODIPine (Norvasc) AND losartan (Cozaar)

  • ONE 5 mg amLODIPine PLUS ONE 100 mg losartan po Daily
  • ONE 10 mg amLODIPine PLUS ONE 100 mg losartan po Daily

amLODIPine-olmesartan (Azor)                                                                   

  • 5 mg-40 mg tablet oral Daily                                                        
  • 10 mg-40 mg tablet oral Daily

amLODIPine (Norvasc) AND valsartan (Diovan)

  • ONE 5 mg amLODIPine PLUS ONE 320 mg valsartan  po Daily
  • ONE 10 mg amLODIPine PLUS ONE 320 mg valsartan po daily

Reviewed: April 27, 2010

Last updated: Dec. 19, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved